Table 1.

A comparison of this data to published series of patients with primary aneurysmal bone cysts.

	Resection			Curettage			Polidocanol			Denosumab
	CR	SD	PD	CR	SD	PD	CR	SD	PD	CR	SD	PD
This study	6 (100%)	0 (0%)	0 (0%)	44 (67%)	10 (15%)	12 (18%)	0 (0%)	1 (33%)	2 (67%)	0 (0%)	2 (100%)	0 (0%)
Basarir et al. [26]	19 (100%)	0 (0%)	0 (0%)	27 (77%)		8 (23%)
Brosjö et al. [27]							37 (97%)		1 (3%)
Dormans et al. [28]				37 (18%)		8 (82%)
Erol et al. [29]	5 (100%)	0 (0%)	0 (0%)	52 (93%)		0 (0%)
Flont et al. [30]	10 (100%)	0 (0%)	0 (0%)	14 (85%)		2 (15%)
Gibbs et al. [31]	6 (100%)	0 (0%)	0 (0%)	30 (88%)		4 (12%)
Kececi B. et al. [17]	9 (100%)	0 (0%)	0 (0%)	66 (87%)	0 (0%)	10 (13%)
Kurucu et al. [32]										6 (67%)		3 (33%)
Kurucu et al. [32]										6 (67%)		3 (33%)
Mankin et al. [33]				120 (80%)		30 (20%)
Palmerini et al. [15]										2 (22%)	7 (78%)	0 (0%)
Peeters et al. [34]				76 (95%)		4 (5%)
Ramirez et al. [35]				21 (72%)		8 (28%)
Rastogi et al. [36]							48 (67%)	22 (30%)	2 (3%)
Reddy et al. [11]				162 (85%)		28 (15%)
Schreuder et al. [34]				76 (95%		4 (5%)
Schulte et al. [37]				33 (80%)		8 (20%)
Shooshtarizadeh et al. [38]				33 (87%)	0 (0%)	5 (13%)
Solooki et al. [39]	4 100%	0 (0%)	0 (0%)	30 (94%)	0 (0%)	2 (6%)
Varshney et al. [23]				39 (85%)	0 (0%)	7 (15%)	42 (93%)	0 (0%)	3 (7%)
Vergel De dios et al. [3]	17 (100%)	0 (0%)	0 (0%)	107 (79%)	0 (0%)	29 (21%)
Wang et al. [21]				30 (97)	0 (0%)	1 (3%)